NZ512256A - Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus - Google Patents
Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitusInfo
- Publication number
- NZ512256A NZ512256A NZ51225601A NZ51225601A NZ512256A NZ 512256 A NZ512256 A NZ 512256A NZ 51225601 A NZ51225601 A NZ 51225601A NZ 51225601 A NZ51225601 A NZ 51225601A NZ 512256 A NZ512256 A NZ 512256A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cells
- injected
- polyacrylamide gel
- cultivated
- diabetes mellitus
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A polyacrylamide gel is useful in the preparation of a medicament for introducing into the tissue of a mammal to form a connective tissue capsule. Transplanted heterologous cells are then inserted into the capsule formed in the mammal and the cells are cultivated. The transplanted cells produce biologically active components, induce immunity or supplement levels of a substance that is either deficient or absent in the mammal. It is useful for the treatment of diabetes mellitus whereby the cells may be pancreatic b-cells and in treatment of cancer Also described is a method of cultivating heterologous cells within a non-human mammal, which comprises introducing into the tissue a polyacrylamide gel that forms a connective tissue capsule and subsequently introducing the heterologous cells into the capsule.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000116208A RU2165263C1 (en) | 2000-06-23 | 2000-06-23 | Method of treatment of patients with diabetes mellitus |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ512256A true NZ512256A (en) | 2002-10-25 |
Family
ID=20236573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ51225601A NZ512256A (en) | 2000-06-23 | 2001-06-08 | Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU784765C (en) |
NZ (1) | NZ512256A (en) |
RU (1) | RU2165263C1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1498142B1 (en) | 2002-04-10 | 2007-03-21 | Obschestvo S Organichennoy Otvetstvennostyu "Vitagel" | Polyfunctional biocompatible hydrogel and method for the production thereof |
TW202006136A (en) * | 2010-05-07 | 2020-02-01 | 北卡羅來納大學教堂山 | Method of engrafting cells from solid tissues |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6972194B1 (en) * | 1999-12-08 | 2005-12-06 | Dmitry Vladimirovich Zybin | Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic and xenogenic cells |
-
2000
- 2000-06-23 RU RU2000116208A patent/RU2165263C1/en not_active IP Right Cessation
-
2001
- 2001-06-07 AU AU51795/01A patent/AU784765C/en not_active Ceased
- 2001-06-08 NZ NZ51225601A patent/NZ512256A/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2165263C1 (en) | 2001-04-20 |
AU5179501A (en) | 2002-01-10 |
AU784765B2 (en) | 2006-06-15 |
AU784765C (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4083A (en) | Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals | |
GB0001309D0 (en) | Valve arrangement | |
WO2002004001A3 (en) | A composition for the delivery of live cells and methods of use | |
DE60126637D1 (en) | MICROSTRUCTURES FOR THE TREATMENT AND PREPARATION OF THE SKIN | |
WO2003002243A3 (en) | Method and device for electrochemical formation of therapeutic species in vivo | |
ATE340581T1 (en) | METHOD FOR TREATING PROSTATE DISEASES USING DELAYED AND/OR EXTENDED RELEASE VITAMIN D FORMULATIONS | |
ID22689A (en) | METHODS FOR ACTIVATING CELLS THAT PROVIDE HUMAN ANTIGENT PROPERTIES, ACTIVATED CELLS THAT INDICATE HUMAN ANTIGENT PROPERTIES, AND ITS USE | |
AU576365B2 (en) | Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas | |
AU7432796A (en) | Retrievable bioartificial implants | |
GB0500787D0 (en) | Integration of meningococcal conjugate vaccination | |
EP1555955A4 (en) | Method for administering thermotherapy to prevent the growth of tumors | |
BR9612051A (en) | Medical implant | |
DE69633278D1 (en) | DEVICE FOR DELIVERING A SELECTED MOLECULE INTO THE CIRCUIT SYSTEM | |
ATE212230T1 (en) | METHODS OF DISEASE TREATMENT USING SERTOLI CELLS AND ALLOTRANSPLANT OR XENOTRANSPLANT | |
WO2007030512A3 (en) | Graft implant containing drug crystals | |
AU2002343045A1 (en) | A needleless injector drug capsule and a method for filling thereof | |
WO2001023421A3 (en) | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease | |
AU2001265151A1 (en) | Method of stimulating hair growth | |
WO2004011631A3 (en) | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus | |
NZ512256A (en) | Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus | |
ATE382378T1 (en) | IMPLANT MATERIAL | |
WO2003059262A3 (en) | Method and composition for treating and preventing hiv infection and aids | |
EP1151756A4 (en) | Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus | |
DK1377320T3 (en) | Polynucleotide binding complexes comprising sterols and saponins | |
DE69734349D1 (en) | TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
ASS | Change of ownership |
Owner name: VERCELL BIOTECHNOLOGY BV, NL Free format text: OLD OWNER(S): ALEXEI GENNADIEVICH KOTELEVITS; SERGEI EVGENIEVICH SEVERIN; VLADIMIR KONSTANTINOVICH SOLOGUB; DMITRY VLADIMIROVICH ZYBIN |
|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |